Cancer ImmunotherapiesBy bolstering the immune system, you can improve your body’s ability to avoid damage from infectious agents and mutated cells. As well, by blocking the mechanisms tumours use to suppress the immune system, you can enjoy the maximum benefit yours provides and increase the speed and strength with which it responds to the perceived threat of cancer. Right now, your immune system needs to be your top priority. The human body possesses an amazing ability to protect itself from all kinds of harm and is constantly engaged in neutralizing internal and external danger. The immune system is a group of mechanisms that protects against disease by identifying and killing pathogens, germs, mutated cells, and tumours.
|
Most importantly, it can distinguish between dangerous elements and healthy cells. With all our participants we suggest agents that can aid the immune system’s ability to attack cancer by optimizing the function of natural killer cells (NK) and cytotoxic T-cells (Tc ). NK cells can kill a broad range of cancer cells; Tc cells target cancer cells that express specific proteins not produced by healthy tissues. Though immune cells rarely can destroy large tumors, they might kill the small nests of tumor cells that give rise to new metastases or that can cause a recurrence of cancer following a remission. Therefore, boosting activity of NK cells and Tc cells is our first piece of immune-stimulation therapy.
|
Types of cancer immunotherapyMonoclonal antibodies (MABs):
Monoclonal antibodies (MABs) are a type of targeted drug therapy. These drugs recognise and find specific proteins on cancer cells. There are many different MABs to treat cancer. They work in different ways to kill the cancer cell or stop it from growing. They all have names that include 'mab' at the end of their generic name. For example, trastuzumab (Herceptin) and rituximab (Mabthera). Some MABS help the immune system to attack and kill cancer cells. These MABs are also a type of immunotherapy. What are monoclonal antibodies (MABs)? Antibodies are found naturally in our blood and help us to fight infection. MAB therapies mimic natural antibodies but are made in a laboratory. Monoclonal means all one type. So each MAB therapy is a lot of copies of one type of antibody. Many different MABs are available to treat cancer. They work in different ways and some work in more than one way.
Checkpoint InhibitorsCheckpoint inhibitors are a type of immunotherapy. They are a treatment for cancers such as melanoma skin cancer and lung cancer.These drugs block different checkpoint proteins. You might also hear them named after these checkpoint proteins – for example, CTLA-4 inhibitors, PD-1 inhibitors and PD-L1 inhibitors. Examples of checkpoint inhibitors include pembrolizumab (Keytruda), ipilimumab (Yervoy), nivolumab (Opdivo) and atezolizumab (Tecentriq).
What are checkpoint inhibitors? Checkpoint inhibitors are a type of immunotherapy. They block proteins that stop the immune system from attacking the cancer cells. Cancer drugs do not always fit easily into a certain type of treatment. This is because some drugs work in more than one way and belong to more than one group. Checkpoint inhibitors are also described as a type of monoclonal antibody or targeted treatment. How do checkpoint inhibitors work? Our immune system protects us from disease, killing bacteria and viruses. One main type of immune cell that does this is called a T cell. T cells have proteins on them that turn on an immune response and other proteins that turn it off. These are called checkpoint proteins. Some checkpoint proteins help tell T cells to become active, for example when an infection is present. But if T cells are active for too long, or react to things they shouldn’t, they can start to destroy healthy cells and tissues. So other checkpoints help tell T cells to switch off. Some cancer cells make high levels of proteins. These can switch off T cells, when they should really be attacking the cancer cells. So the cancer cells are pushing a stop button on the immune system. And the T cells can no longer recognise and kill cancer cells. Drugs that block checkpoint proteins are called checkpoint inhibitors. They stop the proteins on the cancer cells from pushing the stop button. This turns the immune system back on and the T cells are able to find and attack the cancer cells. Types These drugs block different checkpoint proteins including:
PD-1Checkpoint inhibitors that block PD-1 include:
cancers of the urinary tract. The urinary tract includes the:
4Ipilimumab (Yervoy) is a checkpoint inhibitor drug that blocks CTLA-4. It is a treatment for advanced melanoma and advanced renal cell cancer. PD-L1 Checkpoint inhibitors that block PD-L1 include:
|